Literature DB >> 16285159

CD3-antibody therapy in new-onset type 1 diabetes mellitus.

I David Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285159

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Addition of rapamycin to anti-CD3 antibody improves long-term glycaemia control in diabetic NOD mice.

Authors:  Shira Perl; Jordan Perlman; R P Weitzel; Oswald Phang; Matthew M Hsieh; John Tisdale
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.